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Abstract
Congestive hepatopathy results from passive venous congestion often in the setting of right heart failure.
Injury to the liver due to congestion is often asymptomatic and may be difficult to recognize and diagnose.
The degree of elevations in aminotransferases varies in cases of congestive hepatopathy but usually stays
within two to three times the upper limit of normal. Here, we report an interesting case of congestive
hepatopathy that presented with striking elevations of aminotransferases in the 2000s international
units/liter a few days after admission without concurrent hypotension.

Categories: Cardiology, Internal Medicine, Gastroenterology
Keywords: shock liver, elevated aminotransferases, ischemic hepatopathy, congestive heart failure, congestive
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Introduction
The liver’s high metabolic activity and complex vascularization make it susceptible to hemodynamic
changes [1]. Congestive hepatopathy occurs secondary to various cardiovascular conditions that lead to
persistent passive venous congestion in the liver [1]. Congestive hepatopathy often results from right heart
failure but can also occur from other pathologies in the inferior vena cava or hepatic veins [2]. Common
causes of this include congestive heart failure, cor pulmonale, valvulopathies, right ventricular dysfunction,
constrictive pericarditis, and severe pulmonary hypertension [3]. Congestive hepatopathy is also common in
patients with congenital heart disease who have had a Fontan procedure, which directs systemic venous
return to the pulmonary artery, bypassing the right ventricle [3].
Diagnosis of this condition remains challenging as clinical manifestations, laboratory testing, and imaging
findings are nonspecific. Patients with congestive hepatopathy usually remain asymptomatic and diagnosis
may only be suspected after abnormal liver biochemical tests during routine evaluation [2]. The degree of
elevation in aminotransferases varies in cases of congestive hepatopathy but typically stays within two to
three times the upper limits of normal [4]. Occasionally patients may have higher levels likely due to
coexisting ischemic hepatitis from decreased cardiac output [4,5]. Drastic elevations in aminotransferases
exceeding 1000 international units/liter have been reported in patients with shock or hypotension due to
heart failure [6]. Here, we report an interesting case of congestive hepatopathy that presented with striking
elevations of aminotransferases in the 2000s international units/liter a few days after admission without
concurrent hypotension or shock.

Case Presentation
A 72-year-old male presented to the emergency department with the chief complaint of increased shortness
of breath, orthopnea, altered mental status, and slightly slurred speech. The patient underwent dialysis the
day before presenting to the emergency department and had three liters of fluid removed. He went to the
hospital due to persistent shortness of breath and increased oxygen requirement. He has a past medical
history of end-stage renal disease on hemodialysis, atrial fibrillation on warfarin, right-sided heart failure
with a last known ejection fraction of 54% (two years ago), hypertension, type 2 diabetes mellitus, gout, and
hyperlipidemia. He denied any history of liver disease. The patient was a non-smoker, non-alcoholic, and
had a noncontributory family history. His past surgical history included a right hip replacement. His home
medications include allopurinol, bumetanide, lisinopril, metoprolol succinate, nifedipine, neutral protamine
hagedorn insulin, pravastatin, sertraline, warfarin, and trazodone. On examination, he was tachypneic and
tachycardic, but other vitals were stable. Lungs were mostly clear with mild rales in the bases bilaterally. The
cardiac exam showed tachycardia with a regular rhythm and no extra heart sounds. His abdomen was soft,
non-tender, and non distended. His mental status was alert and oriented to person and place, but not time.
His speech was slightly slurred, but cranial nerves, muscular strength, and sensation were intact.
Please see Table 1 and Table 2 for the initial complete blood count and comprehensive metabolic panel.
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Arterial blood gas on admission showed respiratory alkalosis and metabolic acidosis (Table 3). His initial
lactate level was 4.6 mmol/L. He was also noted to have a supratherapeutic international normalized ratio
(INR) of 6.6 with a prothrombin time of 64.7 seconds and a partial thromboplastin time of 54.2 seconds.
Brain natriuretic peptide (BNP) was 1896 pg/mL and COVID- 19 polymerase chain reaction was negative.
Aminotransferases were elevated with aspartate aminotransferase (AST) and alanine aminotransferase (ALT)
being 565 international units/liter and 533 international units/liter, respectively. Chest radiograph showed a
moderate right pleural effusion with an ill-defined nodular density and cardiomegaly with congestive
changes (Figure 1). A non-contrast computed tomography of the head was negative for bleeding or masses.
The patient was given furosemide 80 milligrams, as a one-time push in the emergency department.
Nephrology was consulted and urgent dialysis was done to remove volume and correct the acidosis.
Intravenous furosemide of 40 milligrams per day was ordered, warfarin was withheld, an echocardiogram
was ordered, cardiology was consulted, and he was admitted to the hospital.

Test

Value

Reference Range

White Blood Cell Count

12.4 th/uL

4.8 – 10.8 th/uL

Red Blood Cell Count

4.50 mil/uL

4.70 – 6.10 mil/uL

Hemoglobin

13.1 g/dL

13.5 – 18.0 g/dL

Hematocrit

41.2 %

40.0 – 54.0 %

Mean Corpuscular Volume

92 fL

80 – 94 fL

Mean Corpuscular Hemoglobin

29.1 pg

27.0 – 31.0 pg

Mean Corpuscular Hemoglobin Concentration

31.8 g/dL

33.0 – 37.0 g/dL

Red Cell Distribution Width

15.9 %

11.5 – 14.5 %

Platelet Count

338 th/uL

150 – 450 th/uL

Absolute Neutrophil Count

10.7 th/uL

2.30 – 8.10 th/uL

Neutrophil Percent

86.1 %

40.0 – 80.0 %

Lymphocyte Percent

5.8 %

20.0 – 40.0 %

Monocyte Percent

7.1 %

0.0 – 10.0 %

Eosinophil Percent

0.0 %

0.0 – 5.0 %

Basophil Percent

0.2 %

0.0 – 2.0 %

Immature Granulocyte Percent

0.8 %

0.0 – 1.0 %

TABLE 1: Initial Complete Blood Count
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Test

Value

Reference Range

Sodium

133 mmol/L

137 – 145 mmol/L

Potassium

5.2 mmol/L

3.5 – 5.0 mmol/L

Chloride

95 mmol/L

98 – 107 mmol/L

Bicarbonate

15 mmol/L

22 – 30 mmol/L

Anion Gap

23 mmol/L

5 – 15 mmol/L

Glucose

82 mg/dL

75 – 110 mg/dL

Blood Urea Nitrogen

36 mg/dL

9 – 20 mg/dL

Creatinine

3.6 mg/dL

0.8 – 1.5 mg/dL

Glomerular Filtration Rate Non-African American

16.8 mL/min

Glomerular Filtration Rate African American

20.3 mL/min

Calcium

9.6 mg/dL

8.4 – 10.2 mg /dL

Total Bilirubin

2.5 mg/dL

0.1 – 1.3 mg/dL

Alkaline Phosphatase

156 U/L

38 – 126 U/L

Aspartate Aminotransferase

565 U/L

5 – 34 U/L

Alanine Aminotransferase

553 U/L

11 – 55 U/L

Total Protein

8.4 g/dL

6.3 – 8.2 g/dL

Albumin

3.9 g/dL

3.2 – 5.0 g/dL

TABLE 2: Initial Comprehensive Metabolic Panel

Test

Value

Reference Range

pH

7.40

7.35 – 7.45

pCO2

22.0 mmHg

35.0 – 45.0 mmHg

pO2

61.5 mmHg

80.0 – 90.0 mmHg

Bicarbonate

13.5 mm/L

22.0 – 26.0 mm/L

Base Excess

-9.2 mm/L

-2 – +2 mm/L

Oxygen Saturation

87.9%

95.0 – 100 %

Carboxyhemoglobin

1.3%

0.0 – 3.0 %

Methemoglobin

0.7 g/dL

0.0 – 1.5 g/dL

TABLE 3: Initial Arterial Blood Gas
Abbreviations: pH – potential hydrogen, pCO2 – partial pressure of carbon dioxide, pO2 – partial pressure of oxygen
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FIGURE 1: Initial Chest Radiograph
Anterior-posterior chest radiograph: Blue Arrow: moderate right pleural effusion with ill-defined nodular density.
White arrow: Cardiomegaly with congestive changes.

On the second day, his transaminitis significantly worsened with aspartate aminotransferase (AST) and
alanine transaminase (ALT) increasing to 1988 international units/liter and 1705 international units/liter,
respectively. A viral hepatitis panel and right upper quadrant ultrasound were ordered. Hepatology was
consulted and medications were reviewed. The patient’s vitals remained stable with no episodes of
hypotension. On the third day, transaminitis continued to worsen with AST and ALT increasing to 2466
international units/liter and 2352 international units/liter, respectively. Despite the drastic elevations in his
aminotransferases, he denied any changes in mental status, his vitals remained stable, and his prothrombin
time returned to normal limits. The viral hepatitis panel was negative, and the right upper quadrant
ultrasound was normal. After a review of his medications, pravastatin was discontinued for potential
hepatotoxicity and worsening of aminotransferases. His home medication allopurinol was not continued
upon admission. The echocardiogram ordered on admission showed an ejection fraction of 33%, which was
reduced from 54% two years ago. Echocardiogram also showed a right ventricular systolic pressure of 67.0
mmHg, indicating severe pulmonary hypertension. The consulted hepatologist concluded that the
transaminitis was likely due to a combination of hepatic congestion secondary to severe pulmonary
hypertension, volume overload, and ischemia from congestive heart failure. The elevations in
aminotransferases were likely from the initial insult on presentation. Continued dialysis and volume
removal were recommended. Over the next few days, he received his scheduled dialysis and his liver
enzymes slowly returned to normal limits.

Discussion
Congestive hepatopathy is a pathological condition that describes liver damage often from right heart failure
or a variety of cardiovascular conditions resulting in passive venous congestion in the liver [1]. Patients with
this condition are usually asymptomatic and may only be suspected from abnormal liver biochemical tests on
routine evaluation [2]. Symptomatic patients can present with dull right upper quadrant pain, jaundice, or
ascites [7]. Splenomegaly is rare but can occur in certain patients [7]. The hepatojugular reflex is usually
present and can be useful for distinguishing hepatic congestion from primary intrahepatic liver disease or
Budd-Chiari syndrome [7]. In our patient, no hepatomegaly, right upper quadrant pain, ascites, or jaundice
was noted. The hepatojugular reflex and jugular venous distention were not assessed.
Laboratory findings are nonspecific and of little use for diagnosis as they remain in ranges near normal until
the advanced stages of the disease [8]. The most common liver biochemical abnormality is
hyperbilirubinemia with total bilirubin that rarely exceeds 3 mg/dL [9]. Serum alkaline phosphatase is
usually normal or slightly elevated in acute heart failure even in the presence of jaundice [7]. Alkaline
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phosphatase may also be elevated in the setting of chronic heart failure [7]. Serum aminotransferases may be
elevated up to two to three times the normal value and may occasionally have higher levels likely due to
coexisting ischemic hepatitis following decreased cardiac output [5]. Drastic elevations in aminotransferases
exceeding 1000 international units/liter have been seen in patients with hypotension due to heart failure [6].
On presentation, our patient presented with a total bilirubin of 2.5 mg/dL, alkaline phosphatase of 156
international units/liter, AST of 565 international units/L, and an ALT of 554 international units/liter.
Throughout our patient’s hospital course, his total bilirubin never exceeded 3 mg/dL, his alkaline
phosphatase remained in the 135 - 150 international units/liter range, and no episodes of hypotension
occurred. Our patients AST and ALT peaked at 2466 international units/liter and 2352 international
units/liter, respectively, a few days after presentation.
Diagnosis of hepatic congestion involves both clinical and laboratory investigations. Careful history review
for risk factors for liver disease, history of liver disease, illicit drug use, alcohol use, and hepatotoxic
medications need to be evaluated [9]. Laboratory testing for viral hepatitis and N-terminal-pro-BNP can
help aid in the diagnosis [10]. N-terminal-pro-BNP in one study was found to distinguish heart failurerelated ascites from cirrhosis with a sensitivity of 98 percent [10]. In our patient, N-terminal-pro-BNP was
not ordered, but BNP was 1896 pg/mL. Electrocardiograms and echocardiography are also done to evaluate
cardiac function. When evaluating a patient with congestive hepatopathy, other diagnoses to consider
include viral hepatitis, autoimmune hepatitis, Wilson disease, alpha-1 antitrypsin deficiency, Budd-Chiari
syndrome, and thyroid dysfunction [7,9]. Ultrasonography with Doppler studies of the right upper quadrant
is warranted to rule out possible thrombosis and Budd-Chiari syndrome [7]. Characteristic ultrasound
findings of congestive hepatopathy seen in the inferior vena cava and hepatic veins along with a detailed
clinical history can also help confirm the diagnosis [11]. In patients with ascites, diagnostic paracentesis may
aid in the diagnosis with the serum-to ascites albumin gradient being greater or equal to 1.1, demonstrating
portal hypertension [12]. Improvement in aminotransferases with the treatment of the underlying cardiac
condition also aids in the diagnosis [6,8]. A liver biopsy can confirm the diagnosis but is rarely required [2].
After his medications were reviewed, pravastatin was the only hepatotoxic medication found and was
discontinued. Pravastatin was unlikely to be the cause of his significant transaminitis as he had taken it for
many years without issues. The viral hepatitis panel and right upper quadrant ultrasound were
unremarkable. An echocardiogram was ordered that demonstrated a reduced ejection fraction of 33% and a
right ventricular systolic pressure of 67.0 mmHg indicating severe pulmonary hypertension. Thyroid studies
were within normal limits. Other labs for autoimmune hepatitis, Wilson disease, and alpha-1 antitrypsin
deficiency were not ordered due to suggestive clinical, laboratory, and imaging findings.
Management of congestive hepatopathy revolves around treating the underlying heart disease [2,9]. Hepatic
congestion may respond well to diuretics, although excess diuresis should be cautioned to avoid impaired
hepatic perfusion [13]. Patients may also present with an underlying coagulopathy, increasing sensitivity to
warfarin anticoagulation [14]. Coagulation status should be monitored carefully along with other drugs that
require hepatic metabolism. In our patient, urgent dialysis was done to remove volume overload suggested
by clinical symptoms, and a chest x-ray showed cardiomegaly with congestive changes. After removing
excessive volume with a few dialysis sessions, aminotransferases improved. Our patient also presented with
a supratherapeutic INR of 6.7 and a prothrombin time and partial thromboplastin time of 65.6 seconds and
54.2 seconds, respectively. No active bleeding was noted, and warfarin was withheld. Coagulation labs
normalized over time with scheduled dialysis.

Conclusions
This case presents an interesting manifestation of congestive hepatopathy with aminotransferases in the
2000s international units/liter without hypotension. The diagnosis of congestive hepatopathy is challenging
as laboratory testing and clinical features vary and are nonspecific. When evaluating a patient with
suspected congestive hepatopathy it is important to access cardiac function and treat the underlying heart
disease. Ultrasound of the liver and hepatic vasculature may also aid in the diagnosis. More research should
be conducted to determine a consistent diagnostic and treatment plan.
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